09:22am GSK : JP Morgan reiterates its Sell rating ZD
09:02am Escalate, De-Escalate, Repeat Zonebourse
01:03am Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality RE
01-21 GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026 BU
01-21 GSK : UBS remains Neutral ZD
01-21 RTW Biotech welcomes GSK deal to buy RAPT Therapeutics AN
01-21 GSK enters agreement to acquire RAPT Therapeutics AQ
01-20 PRESS DIGEST-Financial Times - Jan 21 RE
01-20 S&P 500, Nasdaq slump to one-month lows as Greenland dispute triggers global selloff RE
01-20 Top Midday Gainers MT
01-20 European Stocks Close Lower in Tuesday Trading; UK Unemployment Rises to 5.1% MT
01-20 Global drugmakers rush to boost US presence as tariff threat looms RE
01-20 GSK : Receives a Sell rating from Barclays ZD
01-20 Sector Update: Health Care Stocks Decline Premarket Tuesday MT
01-20 Traders Digest Trump's Greenland Demands, US Equity Futures Down Pre-Bell MT
01-20 GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million BU
01-20 Greenland, Tariffs, and the Quiet Revolt of the Bond Market Zonebourse
01-20 Top Premarket Gainers MT
01-20 RAPT Therapeutics Shares Jump Following Acquisition by GSK DJ
01-20 North American Morning Briefing : Futures Fall as Atlantic Tensions Rise DJ
01-20 Rapt Therapeutics Inc in case of termination, company to pay to GSK termination fee in cash equal to $78.4 million RE
01-20 GSK's Tesaro Licenses Alteogen Enzyme Technology MT
01-20 Deals of the day-Mergers and acquisitions RE
01-20 Wall Street skids to near three-week low as Greenland dispute triggers global sell-off RE
01-20 GSK to Bolster Immunology Pipeline With $2.2 Billion Rapt Therapeutics Acquisition MT
No results for this search